LEUKEMIA, ACUTE LYMPHOBLASTIC
Clinical trials for LEUKEMIA, ACUTE LYMPHOBLASTIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, ACUTE LYMPHOBLASTIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, ACUTE LYMPHOBLASTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets tough leukemia in adults
Disease control OngoingThis study tests a drug called ponatinib combined with chemotherapy as a first treatment for adults aged 18-65 with a high-risk type of acute lymphoblastic leukemia (BCR/ABL1-like ALL). The goal is to see if this targeted approach can make the cancer undetectable in the bone marr…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated May 26, 2026 11:14 UTC
-
New hope for kids with leukemia who Can't take standard drug
Disease control NO_LONGER_AVAILABLEThis study provides Erwinase, a different form of chemotherapy, to children with acute lymphoblastic leukemia (ALL) who have had allergic reactions to the usual L-asparaginase drugs. The goal is to offer a safe treatment option for these patients. Participants must have confirmed…
Matched conditions: LEUKEMIA, ACUTE LYMPHOBLASTIC
Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC